FDA Approves Levaquin Short-Course Therapy Treatment Appeals court rules in favor of Novartis; stops Teva from selling generic Famvir for now Chephalon finalizes label revisions for Provigil Industry, health groups’ alarm grows as tamper-proof deadline approaches Congress will not legislate generic biotech medications New York joins state lawsuits over Vioxx Eli Lilly settles with whistleblower for $100,000 Purdue pays out over $7 million over OxyContin Target offers flavored medications for kids FDA approves new dosage of MedPointe's Soma First Previous 2695 2696 2697 2698 2699 Next Last
